Ema Lupsic
Belgrade, SE, Serbia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Novel Adamantane-Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells.
Journal: Molecules (Basel, Switzerland)
Published: November 21, 2025
Novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity.
Journal: Bioorganic chemistry
Published: October 07, 2025
Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells.
Journal: Bioorganic chemistry
Published: July 06, 2025
Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures.
Journal: Current issues in molecular biology
Published: March 07, 2025
LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models.
Journal: Pharmaceutics
Published: December 12, 2024
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors.
Journal: Cancers
Published: April 26, 2024
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells.
Journal: Diagnostics (Basel, Switzerland)
Published: November 14, 2023
LC-ESI QToF MS Non-Targeted Screening of Latex Extracts of Euphorbia seguieriana ssp. seguieriana Necker and Euphorbia cyparissias and Determination of Their Potential Anticancer Activity.
Journal: Plants (Basel, Switzerland)
Published: October 27, 2023
Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells.
Journal: Bioorganic chemistry
Published: March 29, 2023
Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors.
Journal: Life (Basel, Switzerland)
Published: August 15, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026